Form 4: Schrodinger EVP, CTO & COO, Software, Kenneth Patrick Lorton, Reports Acquisition of Stock Options and Restricted Stock Units
SEC Form 4 Filing
Kenneth Patrick Lorton, EVP, CTO & COO, Software at Schrodinger, Inc., reports the acquisition of 50,000 stock options and 12,500 restricted stock units (RSUs) on March 3, 2025.
Summary
- On March 3, 2025, Kenneth Patrick Lorton, EVP, CTO & COO, Software at Schrodinger, Inc., was granted 50,000 stock options with an exercise price of $21.24.
- These options vest 25% on March 3, 2026, and the remainder in equal monthly installments through March 3, 2029.
- Lorton also received 12,500 restricted stock units (RSUs) under the Issuer's 2022 Equity Incentive Plan, as amended.
- These RSUs vest in equal installments on March 4 of 2026, 2027, 2028, and 2029, contingent upon continued service with the company.
- Following these transactions, Lorton beneficially owns 53,576 shares of common stock, including 16,585 unvested RSUs, and 50,000 stock options.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The granting of stock options and RSUs is a standard practice and generally viewed favorably as it aligns management's interests with shareholders. There are no explicit negative indicators.
Positives
- The grant of stock options and RSUs aligns Lorton's interests with those of the shareholders, incentivizing him to contribute to the company's long-term success.
- The vesting schedules for both the stock options and RSUs encourage continued service with the company.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedules of the stock options and RSUs.
Industry Context
Granting stock options and RSUs to key executives is a common practice in the technology and pharmaceutical industries to incentivize performance and retain talent. Schrodinger, as a company operating at the intersection of these sectors, follows this trend.
Comparison to Industry Standards
- Stock option grants are a standard component of compensation packages for executives in publicly traded companies, particularly in the tech and biotech sectors.
- Companies like Google, Amazon, and Moderna also use stock options and RSUs to align executive compensation with shareholder value.
- The vesting schedules described are typical, with vesting occurring over a period of several years to encourage long-term commitment.
Stakeholder Impact
- Shareholders may view the grant of stock options and RSUs positively, as it incentivizes management to increase shareholder value.
- Employees may see this as a positive sign, indicating the company's commitment to retaining key personnel.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Date of the grant of stock options and RSUs. |
| 03/03/2025 | Date the stock options were granted. |
| 03/03/2026 | First vesting date for 25% of the stock options. |
| 03/04/2026 | First vesting date for the RSUs. |
| 03/03/2029 | Final vesting date for the stock options. |
| 03/04/2029 | Final vesting date for the RSUs. |
| 03/03/2035 | Expiration date for the stock options. |
| 03/04/2025 | Date of the signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.